Steve Liapis
Angel · Massachusetts
Board director at 3 startups that filed Form D raises since late 2024, mostly in Massachusetts.
- Stages
- Series A to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Sep 2025
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Garuda TherapeuticsFeb 3, 2023
- SEC Form D: Kyverna TherapeuticsNov 7, 2023
- SEC Form D: Merge Bio TherapeuticsSep 17, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.